Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Gutierrez-Camino

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Medical Oncology (Northwood, London, England)|September 15, 2017
Genetic susceptibility in childhood acute lymphoblastic leukemiaAngela Gutierrez-Camino, Idoia Martin-Guerrero, Africa García-Orad
Medical Oncology (Northwood, London, England)|September 3, 2014
SLC19A1 hot spot for MTX plasma concentrationAngela Gutierrez-Camino, Elixabet Lopez-Lopez, Africa Garcia-Orad
International Journal of Molecular Sciences|May 14, 2025
Long Circulating RNAs Packaged in Extracellular Vesicles: Prospects for Improved Risk Assessment in Childhood B-Cell Acute Lymphoblastic LeukemiaLucas Poncelet, Chantal Richer, Angela Gutierrez-Camino, et al.
Journal of the National Cancer Institute|September 10, 2013
Re: novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populationsElixabet Lopez-Lopez, Angela Gutierrez-Camino, Idoia Martin-Guerrero, et al.
Drug Metabolism and Personalized Therapy|March 6, 2017
Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the GRIA1 geneMaria Lopez-Santillan, Leire Iparraguirre, Idoia Martin-Guerrero, et al.
Epigenomics|December 14, 2019
miRNA deregulation in childhood acute lymphoblastic leukemia: a systematic reviewAngela Gutierrez-Camino, Susana Garcia-Obregon, Elixabet Lopez-Lopez, et al.
Pharmacogenomics|February 23, 2018
Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemiaMaitane Umerez, Susana Garcia-Obregon, Idoia Martin-Guerrero, et al.
Pharmacogenomics|August 27, 2014
Pharmacogenetics of childhood acute lymphoblastic leukemiaElixabet Lopez-Lopez, Angela Gutierrez-Camino, Nerea Bilbao-Aldaiturriaga, et al.
International Journal of Oncology|April 14, 2022
lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic reviewUnai Illarregi, Jaione Telleria, Nerea Bilbao-Aldaiturriaga, et al.
The Pharmacogenomics Journal|February 7, 2019
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemiaIdoia Martin-Guerrero, Angela Gutierrez-Camino, Aizpea Echebarria-Barona, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Medical Oncology (Northwood, London, England)|September 15, 2017
Genetic susceptibility in childhood acute lymphoblastic leukemiaAngela Gutierrez-Camino, Idoia Martin-Guerrero, Africa García-Orad
Medical Oncology (Northwood, London, England)|September 3, 2014
SLC19A1 hot spot for MTX plasma concentrationAngela Gutierrez-Camino, Elixabet Lopez-Lopez, Africa Garcia-Orad
International Journal of Molecular Sciences|May 14, 2025
Long Circulating RNAs Packaged in Extracellular Vesicles: Prospects for Improved Risk Assessment in Childhood B-Cell Acute Lymphoblastic LeukemiaLucas Poncelet, Chantal Richer, Angela Gutierrez-Camino, et al.
Journal of the National Cancer Institute|September 10, 2013
Re: novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populationsElixabet Lopez-Lopez, Angela Gutierrez-Camino, Idoia Martin-Guerrero, et al.
Drug Metabolism and Personalized Therapy|March 6, 2017
Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the GRIA1 geneMaria Lopez-Santillan, Leire Iparraguirre, Idoia Martin-Guerrero, et al.
Epigenomics|December 14, 2019
miRNA deregulation in childhood acute lymphoblastic leukemia: a systematic reviewAngela Gutierrez-Camino, Susana Garcia-Obregon, Elixabet Lopez-Lopez, et al.
Pharmacogenomics|February 23, 2018
Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemiaMaitane Umerez, Susana Garcia-Obregon, Idoia Martin-Guerrero, et al.
Pharmacogenomics|August 27, 2014
Pharmacogenetics of childhood acute lymphoblastic leukemiaElixabet Lopez-Lopez, Angela Gutierrez-Camino, Nerea Bilbao-Aldaiturriaga, et al.
International Journal of Oncology|April 14, 2022
lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic reviewUnai Illarregi, Jaione Telleria, Nerea Bilbao-Aldaiturriaga, et al.
The Pharmacogenomics Journal|February 7, 2019
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemiaIdoia Martin-Guerrero, Angela Gutierrez-Camino, Aizpea Echebarria-Barona, et al.
Pageof 3